HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4- (4- cyclohexyl- 2- methyloxazol- 5- yl)- 2- fluorobenzenesulfonamide

prostaglandin H synthase-2 inhibitor
Also Known As:
JTE 522; JTE-522
Networked: 35 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Miki, Tsuneharu: 3 articles (01/2010 - 12/2002)
2. Mizutani, Yoichi: 3 articles (01/2010 - 12/2002)
3. Kawauchi, Akihiro: 3 articles (01/2010 - 12/2002)
4. Hirakawa, Kosei: 3 articles (02/2007 - 08/2002)
5. Murawaki, Yoshikazu: 2 articles (05/2010 - 11/2007)
6. Nagahara, Takakazu: 2 articles (05/2010 - 11/2007)
7. Li, Yong Nan: 2 articles (01/2010 - 10/2004)
8. Nakanishi, Hiroyuki: 2 articles (01/2010 - 10/2004)
9. Sato, Nodoka: 2 articles (01/2010 - 10/2004)
10. Tendo, Masashige: 2 articles (02/2007 - 07/2005)

Related Diseases

1. Urinary Bladder Neoplasms (Bladder Cancer)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Colonic Neoplasms (Colon Cancer)
5. Colorectal Neoplasms (Colorectal Cancer)

Related Drugs and Biologics

1. Fluorouracil (Carac)
2. Cyclooxygenase 2 (Cyclooxygenase-2)
3. Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
4. Dinoprostone (PGE2)
5. Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
6. N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
7. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
8. Dimenhydrinate (DMH)
9. Cisplatin (Platino)
10. Carrageenan

Related Therapies and Procedures

1. Combination Drug Therapy (Combination Chemotherapy)
2. Aftercare (After-Treatment)
3. Oral Administration